Wednesday, July 13, 2022 4:04:28 PM
Hi everyone:
My name is OncoJock, and I've been writing about advances in cancer medicine since 2009. I bought my first share of NWBO in March of 2021, after writing an educational needs assessment about promising therapies in glioblastoma. I've been reading posts on this board since shortly after I first bought shares. My wife and I now hold shares in four different accounts, and our overall cost basis is $1.27.
Before I write anything else, I wish to thank the people who've been sharing such a wealth of knowledge, experience, and perspective here with their fellow shareholders. In particular, I wish to thank the following iHubbers:
ATLnsider
Flipper44
Skitahoe
Vikinginvest
Hoffman6383
a e kusterer
Thermo
Biosectinvestor
SentimentStocks
Lykiri
Poor Man
Kabunushi
Bright Boy
Basin Street Blues
Hope4Patients
Sojourner55
Doc_Logic
The Danish Dude
I also wish to thank our volunteer moderators XenaLives, sentiment_stocks, HappyLibrarian, BigFootOR, JerryCampbell and Dr. Bala for working so hard to keep this board a pleasant, useful, intellectually stimulating, educational, and (potentially) financially rewarding place to spend our time, do our due diligence, and learn. I've learned a great deal by reading posts here over the past year, and I hope to be able to make my own helpful contributions in the days, weeks, and months ahead.
I also want to say what a pleasure it has been to watch the recent presentations by Dr. Mulholland, Dr. Ashkan, and Dr. Liau regarding results of the phase 3 trial of DCVax-L. I'm proud to own shares in a company that is making such important progress to help patients by developing an effective treatment for such a nasty tumor type as GBM. While I'm as impatient as many of the rest of you when it comes to waiting for the peer-reviewed journal article, news of submissions to regulatory authorities, and announcement of a date for the annual shareholders meeting, it has still been marvelous to witness the success NWBO is enjoying when so many other companies have tried and failed to improve outcomes for patients with both newly diagnosed and recurrent disease.
Finally, I wish to thank my late father, who was a prominent physician as well as a savvy investor in several life science and pharmaceutical companies. Dad left me a grubstake to invest, and he gave me this memorable piece of advice: "Don't risk more than you can afford to lose." I try to remember his prudent approach when it comes to buying shares in NWBO, or any other company.
I look forward to reading more of your posts and writing some of my own.
More later.
-- OncoJock
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM